Sign In
Buy INSP
$40.47
-0.110 (-0.271%)
At Close: Jun 03, 2026
Baron Discovery Fund Q3 2025 Contributors And Detractors
08:00am, Tuesday, 04'th Nov 2025
Baron Discovery Fund ended the quarter up 2.85% but underperformed its benchmark, the Russell 2000 Growth Index. Leading defense technology provider Kratos Defense & Security Solutions contributed to
Inspire Medical Systems, Inc. (INSP) Q3 2025 Earnings Call Transcript
06:56am, Tuesday, 04'th Nov 2025
Inspire Medical Systems, Inc. ( INSP ) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Ezgi Yagci - Vice President of Investor Relations Timothy Herbert - Founder, Chairman, CE
Inspire Medical Systems (INSP) Tops Q3 Earnings and Revenue Estimates
11:58pm, Monday, 03'rd Nov 2025
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $0.6 per share a yea
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook
04:02pm, Monday, 03'rd Nov 2025
MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of in
Inspire Medical Systems, Inc. $INSP Shares Bought by Nisa Investment Advisors LLC
04:03am, Monday, 03'rd Nov 2025
Nisa Investment Advisors LLC boosted its stake in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 783.6% during the undefined quarter, according to the company in its most recent filing with t
Mutual of America Capital Management LLC Sells 532 Shares of Inspire Medical Systems, Inc. $INSP
04:00am, Wednesday, 29'th Oct 2025
Mutual of America Capital Management LLC decreased its stake in Inspire Medical Systems, Inc. (NYSE: INSP) by 12.3% during the undefined quarter, according to the company in its most recent disclosure
Impax Small Cap Fund Q3 2025 Contributors And Detractors
04:26pm, Tuesday, 28'th Oct 2025
Ligand Pharmaceuticals (LGND) (Health Care, Pharmaceuticals) shares rose after announcing adjusted earnings per share that came in ahead of consensus. Acadian Asset Management (AAMI) (Financials, Asse
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
08:00am, Monday, 27'th Oct 2025
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
02:16pm, Monday, 13'th Oct 2025
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
BAK Investors Have Opportunity to Join Braskem S.A. Fraud Investigation with the Schall Law Firm
08:09pm, Saturday, 11'th Oct 2025
LOS ANGELES--(BUSINESS WIRE)---- $INSP--BAK Investors Have Opportunity to Join Braskem S.A. Fraud Investigation with the Schall Law Firm.
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
07:00am, Friday, 10'th Oct 2025
MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025
08:00am, Monday, 06'th Oct 2025
MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2025 after the close of trading on Monday, Nove
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire (INSP) To Contact Him Directly To Discuss Their Options If you purchased or acqu
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP
10:00am, Thursday, 18'th Sep 2025
NEW YORK , Sept. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP
10:00am, Sunday, 14'th Sep 2025
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP).
